Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Combination of a microorganism and a phytosphingosine derivative, composition, methods of use
Area reduction for surface mount package chips
Contamination barrier
Communication apparatus, and method and program for controlling same
Catalysts for hydrodeoxygenation of polyols
High-efficiency preambles for communications systems over pseudo-stationary communication channels
Microcapsules, their use and processes for their manufacture
  Randomly Featured Patents
Systems, devices, methods, and compositions including targeted ferromagnetic structures
Spindle motor with a sealing member
Proximity detection for media proxies
Image waveguide having non-parallel surfaces
Runner's training aid
Extended keyboard user interface
Fluxless solder ball attachment process
Method of making a shoe sole having a preformed insert
Tool evaluation calibrator and method